佰金生命科学(01466)公布中期业绩 拥有人应占溢利217.3万港元 同比扭亏为盈

智通财经
Nov 27

智通财经APP讯,佰金生命科学(01466)公布截至2025年9月30日止六个月的中期业绩,收入为5514.5万港元,同比减少22.22%;公司拥有人应占溢利217.3万港元,同比扭亏为盈;每股盈利0.28港仙。

公告称,扭亏为盈主要由于可换股债券的公平值变动收益及毛利的减幅被抵销所致。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10